A detailed history of Allworth Financial LP transactions in Mannkind Corp stock. As of the latest transaction made, Allworth Financial LP holds 211 shares of MNKD stock, worth $1,569. This represents 0.0% of its overall portfolio holdings.

Number of Shares
211
Previous 211 -0.0%
Holding current value
$1,569
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$4.05 - $5.43 $1,620 - $2,172
-400 Reduced 65.47%
211 $1,000
Q1 2024

Apr 25, 2024

SELL
$3.25 - $5.27 $104 - $168
-32 Reduced 4.98%
611 $2,000
Q4 2023

Jan 24, 2024

BUY
$3.34 - $4.29 $1,442 - $1,853
432 Added 204.74%
643 $2,000
Q4 2022

Jan 13, 2023

BUY
$3.02 - $5.37 $637 - $1,133
211 New
211 $0
Q2 2021

Aug 02, 2021

SELL
$3.61 - $5.45 $361 - $545
-100 Closed
0 $0
Q1 2021

Apr 29, 2021

BUY
$3.14 - $6.14 $314 - $614
100 New
100 $0

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.91B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.